Status:
SUSPENDED
Testing of a Functional Outcome Measure for Those With Visual Field Defects
Lead Sponsor:
NovaVision, Inc.
Conditions:
Hemianopsia, Homonymous
Eligibility:
All Genders
18+ years
Brief Summary
This study is designed in two Phases. In phase 1, the Functional Outcome Measure will be tested to determine its validity and reliability in three populations, subjects that have not had a stroke and ...
Detailed Description
The study will be conducted over 18 months and will be conducted in two phases: Phase 1 In the first phase, we will determine the validity and reliability of Functional Outcome Measure by applying th...
Eligibility Criteria
Inclusion
- Stroke victim
- Read / Speak English (required to respond to the questionaire)
- Ability to provide consent
- Homonymous visual field defect evident on a suprathreshold visual field test (High Resolution Perimetry)
- 18 years fo age and older
Exclusion
- Contraindication to visual stimulation: history of photogenic seizures
- Inability to complete Vision Restoration Therapy
- Significant cognitive impairment
- Complete blindness or the inability to focus on a fixation point
- Severe physical or behavioral limitations
- Aphasia
- Onset of Visual field defect less than 3 months prior to enrollment
Key Trial Info
Start Date :
September 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
190 Patients enrolled
Trial Details
Trial ID
NCT00731796
Start Date
September 1 2007
End Date
December 1 2009
Last Update
March 8 2011
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
NovaVision, Inc.
Boca Raton, Florida, United States, 33431
2
University of Miami Bascom Palmer
Miami, Florida, United States, 33136
3
Emory University School of Medicine Atlanta VA Medical Center Research
Atlanta, Georgia, United States, 30332